OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Trained immunity: Target for prophylaxis and therapy
Athanasios Ziogas, Mariolina Bruno, Roy van der Meel, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1776-1791
Open Access | Times Cited: 27

The Influence of Cross-Reactive T Cells in COVID-19
Peter J. Eggenhuizen, Joshua D. Ooi
Biomedicines (2024) Vol. 12, Iss. 3, pp. 564-564
Open Access | Times Cited: 5

Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5

BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination
Krista E. van Meijgaarden, Wenchao Li, Simone J.C.F.M. Moorlag, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial
Nicole L. Messina, Laure F. Pittet, Ellie McDonald, et al.
Journal of Infection (2024) Vol. 89, Iss. 4, pp. 106245-106245
Open Access | Times Cited: 4

Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
Nicole L. Messina, Susie Germano, Amy W. Chung, et al.
Clinical & Translational Immunology (2025) Vol. 14, Iss. 1
Open Access

Efficacy of BCG Vaccination against COVID-19: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jiayu Wen, Quanxian Liu, Daoyan Tang, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 1154-1154
Open Access | Times Cited: 11

Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells
Alok Kumar Singh, Rulin Wang, Kara A. Lombardo, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107733-107733
Open Access | Times Cited: 11

Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study
Mangaiarkarasi Asokan, Roshni Florina Joan, Sudhir Babji, et al.
The Lancet Regional Health - Southeast Asia (2024) Vol. 22, pp. 100361-100361
Open Access | Times Cited: 3

Differences in Immune Responses in Individuals of Indian and European Origin: Relevance for the COVID-19 Pandemic
Büsra Geckin, Martijn Zoodsma, Gizem Kılıç, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8

BCG revaccination in adults enhances pro-inflammatory markers of trained immunity along with anti-inflammatory pathways
Asma Ahmed, Himanshu Tripathi, Krista E. van Meijgaarden, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107889-107889
Open Access | Times Cited: 6

The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial
Jacent Nassuuna, Ludoviko Zirimenya, Gyaviira Nkurunungi, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 11, pp. e1849-e1859
Open Access | Times Cited: 1

BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
Dilhan J. Perera, Pilar Domenech, George Babuadze, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107612-107612
Open Access | Times Cited: 3

The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination
Esther Taks, Simone J.C.F.M. Moorlag, Konstantin Föhse, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108062-108062
Open Access | Times Cited: 2

The BCG vaccine and SARS-CoV-2: Could there be a beneficial relationship?
Carlos A. Peña-Bates, Ricardo Lascuraín, Vianney Ortiz-Navarrete, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e38085-e38085
Open Access

Protective immune response against Rhodococcus equi: An innate immunity‐focused review
Bibiana Petri da Silveira, Noah D. Cohen, Sara D. Lawhon, et al.
Equine Veterinary Journal (2024)
Open Access

Assessment of Neutralizing Antibodies Against COVID-19: The Impact of Vaccination in Western Rajasthan
Varsha Choudhary, Prabhat Kiran Khatri, Palak Khinvasara, et al.
Indian Journal of Clinical Biochemistry (2024)
Closed Access

Interim results from comparison of immune responses elicited by an inactivated and a vectored SARS-CoV-2 vaccine in seronegative and seropositive participants in India
Mangaiarkarasi Asokan, Roshni Florina Joan, Sudhir Babji, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

BCG vaccination of healthcare workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomised placebo-controlled trial
Juana Claus, Thijs ten Doesschate, Cheyenne Gumbs, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

Page 1

Scroll to top